Experimental metastasis and CTL adoptive transfer immunotherapy mouse model
about
LV305, a dendritic cell-targeting integration-deficient ZVex(TM)-based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response.FXYD5 (dysadherin) may mediate metastatic progression through regulation of the β-Na+-K+-ATPase subunit in the 4T1 mouse breast cancer model.A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies.An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis.
P2860
Experimental metastasis and CTL adoptive transfer immunotherapy mouse model
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Experimental metastasis and CTL adoptive transfer immunotherapy mouse model
@ast
Experimental metastasis and CTL adoptive transfer immunotherapy mouse model
@en
type
label
Experimental metastasis and CTL adoptive transfer immunotherapy mouse model
@ast
Experimental metastasis and CTL adoptive transfer immunotherapy mouse model
@en
prefLabel
Experimental metastasis and CTL adoptive transfer immunotherapy mouse model
@ast
Experimental metastasis and CTL adoptive transfer immunotherapy mouse model
@en
P2093
P2860
P356
P1476
Experimental metastasis and CTL adoptive transfer immunotherapy mouse model
@en
P2093
Mary Zimmerman
Xiaolin Hu
P2860
P356
10.3791/2077
P577
2010-11-26T00:00:00Z